Cvs Health (CVS) Invested Capital (2009 - 2026)

Cvs Health's Invested Capital history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• Quarterly Invested Capital rose 104.92% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136.0 billion (down 31.8% YoY) and the FY2025 annual result came in at $64.6 billion, down 2.57% from the prior year.
• Invested Capital was $2.6 billion for Q1 2026 at Cvs Health, down from $64.6 billion in the prior quarter.
• Across five years, Invested Capital topped out at $66.4 billion in Q2 2024 and bottomed at $1.3 billion in Q1 2025.
• A 5-year average of $34.7 billion and a median of $52.3 billion in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital soared 6598.33% — and 2025, when it plunged 95.42%.
• Cvs Health's Invested Capital stood at $52.3 billion in 2022, then increased by 17.9% to $61.6 billion in 2023, then climbed by 7.56% to $66.3 billion in 2024, then fell by 2.57% to $64.6 billion in 2025, then sank by 96.0% to $2.6 billion in 2026.
• Business Quant data shows CVS's Invested Capital at $2.6 billion in Q1 2026, $64.6 billion in Q4 2025, and $65.8 billion in Q3 2025.